These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 22611042)

  • 1. Stereoselective evasion of P-glycoprotein, cytochrome P450 3A, and hydrolases by peptide prodrug modification of saquinavir.
    Wang Z; Pal D; Mitra AK
    J Pharm Sci; 2012 Sep; 101(9):3199-213. PubMed ID: 22611042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evasion of P-gp mediated cellular efflux and permeability enhancement of HIV-protease inhibitor saquinavir by prodrug modification.
    Jain R; Agarwal S; Majumdar S; Zhu X; Pal D; Mitra AK
    Int J Pharm; 2005 Oct; 303(1-2):8-19. PubMed ID: 16137847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal absorption of novel-dipeptide prodrugs of saquinavir in rats.
    Jain R; Duvvuri S; Kansara V; Mandava NK; Mitra AK
    Int J Pharm; 2007 May; 336(2):233-40. PubMed ID: 17207946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of dipeptide prodrugs of saquinavir with multidrug resistance protein-2 (MRP-2): evasion of MRP-2 mediated efflux.
    Jain R; Agarwal S; Mandava NK; Sheng Y; Mitra AK
    Int J Pharm; 2008 Oct; 362(1-2):44-51. PubMed ID: 18620036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of resveratrol on P-glycoprotein and cytochrome P450 3A in vitro and on pharmacokinetics of oral saquinavir in rats.
    Li J; Liu Y; Zhang J; Yu X; Wang X; Zhao L
    Drug Des Devel Ther; 2016; 10():3699-3706. PubMed ID: 27895462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting SVCT for enhanced drug absorption: synthesis and in vitro evaluation of a novel vitamin C conjugated prodrug of saquinavir.
    Luo S; Wang Z; Patel M; Khurana V; Zhu X; Pal D; Mitra AK
    Int J Pharm; 2011 Jul; 414(1-2):77-85. PubMed ID: 21571053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential roles of P-glycoprotein, multidrug resistance-associated protein 2, and CYP3A on saquinavir oral absorption in Sprague-Dawley rats.
    Usansky HH; Hu P; Sinko PJ
    Drug Metab Dispos; 2008 May; 36(5):863-9. PubMed ID: 18256206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of poly(ethylene glycol)-based saquinavir prodrug conjugates and assessment of release and anti-HIV-1 bioactivity using a novel protease inhibition assay.
    Gunaseelan S; Debrah O; Wan L; Leibowitz MJ; Rabson AB; Stein S; Sinko PJ
    Bioconjug Chem; 2004; 15(6):1322-33. PubMed ID: 15546199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide prodrugs: improved oral absorption of lopinavir, a HIV protease inhibitor.
    Agarwal S; Boddu SH; Jain R; Samanta S; Pal D; Mitra AK
    Int J Pharm; 2008 Jul; 359(1-2):7-14. PubMed ID: 18455890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP3A4-mediated hepatic metabolism of the HIV-1 protease inhibitor saquinavir in vitro.
    Eagling VA; Wiltshire H; Whitcombe IW; Back DJ
    Xenobiotica; 2002 Jan; 32(1):1-17. PubMed ID: 11824416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of gut and hepatic first pass metabolism and secretion of saquinavir in ported rabbits.
    Sinko PJ; Kunta JR; Usansky HH; Perry BA
    J Pharmacol Exp Ther; 2004 Jul; 310(1):359-66. PubMed ID: 15004217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prodrugs of HIV protease inhibitors-saquinavir, indinavir and nelfinavir-derived from diglycerides or amino acids: synthesis, stability and anti-HIV activity.
    Gaucher B; Rouquayrol M; Roche D; Greiner J; Aubertin AM; Vierling P
    Org Biomol Chem; 2004 Feb; 2(3):345-57. PubMed ID: 14747863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced oral absorption of saquinavir with Methyl-Beta-Cyclodextrin-Preparation and in vitro and in vivo evaluation.
    Pathak SM; Musmade P; Dengle S; Karthik A; Bhat K; Udupa N
    Eur J Pharm Sci; 2010 Nov; 41(3-4):440-51. PubMed ID: 20656025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors that restrict the cell permeation of cyclic prodrugs of an opioid peptide, part 3: Synthesis of analogs designed to have improved stability to oxidative metabolism.
    Nofsinger R; Fuchs-Knotts T; Borchardt RT
    J Pharm Sci; 2012 Sep; 101(9):3486-99. PubMed ID: 22411763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docosahexaenoic acid (DHA) inhibits saquinavir metabolism in-vitro and enhances its bioavailability in rats.
    Hirunpanich V; Sato H
    J Pharm Pharmacol; 2006 May; 58(5):651-8. PubMed ID: 16640834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CPY3A4-mediated α-hydroxyaldehyde formation in saquinavir metabolism.
    Li F; Lu J; Ma X
    Drug Metab Dispos; 2014 Feb; 42(2):213-20. PubMed ID: 24212380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bifunctional peptidomimetic prodrugs of didanosine for improved intestinal permeability and enhanced acidic stability: synthesis, transepithelial transport, chemical stability and pharmacokinetics.
    Yan Z; Sun J; Chang Y; Liu Y; Fu Q; Xu Y; Sun Y; Pu X; Zhang Y; Jing Y; Yin S; Zhu M; Wang Y; He Z
    Mol Pharm; 2011 Apr; 8(2):319-29. PubMed ID: 21280612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipeptide prodrug approach to evade efflux pumps and CYP3A4 metabolism of lopinavir.
    Patel M; Sheng Y; Mandava NK; Pal D; Mitra AK
    Int J Pharm; 2014 Dec; 476(1-2):99-107. PubMed ID: 25261710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The disposition of saquinavir in normal and P-glycoprotein deficient mice, rats, and in cultured cells.
    Washington CB; Wiltshire HR; Man M; Moy T; Harris SR; Worth E; Weigl P; Liang Z; Hall D; Marriott L; Blaschke TF
    Drug Metab Dispos; 2000 Sep; 28(9):1058-62. PubMed ID: 10950849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Consequence of Drug-Drug Interactions Influencing the Interplay between P-Glycoprotein and Cytochrome P450 3a: An Ex Vivo Study with Rat Precision-Cut Intestinal Slices.
    Li M; de Graaf IA; Siissalo S; de Jager MH; van Dam A; Groothuis GM
    Drug Metab Dispos; 2016 May; 44(5):683-91. PubMed ID: 26932816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.